SONOMA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$131.00 thousand for the 12-month period ending 2019-03-31, per its 10-K filed 2019-07-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-07-01
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$171.00K.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $992.00K, a 8918.18% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $17.29M.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$48.00K.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2019 was -$131.00K.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2018 was -$201.00K, a 101.10% decline from fiscal 2017.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $18.22M, a 334.84% increase from fiscal 2016.
- SONOMA PHARMACEUTICALS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $4.19M, a 378.97% increase from fiscal 2015.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2019-03-31 | -$131.00K 10-K · filed 2019-07-01 | |||
| 2018-03-31 | -$201.00K 10-K · filed 2019-07-01 | |||
| 2017-06-30 | -$171.00K 10-Q · filed 2017-08-08 | $821.00K derived: sum of 2 quarters · filed 2018-06-26 | $18.11M derived: sum of 3 quarters · filed 2018-06-26 | $18.06M derived: sum of 4 quarters · filed 2018-06-26 |
| 2017-03-31 | $992.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $18.28M derived: sum of 2 quarters · filed 2018-06-26 | $18.23M derived: sum of 3 quarters · filed 2018-06-26 | $18.22M 10-K · filed 2018-06-26 |
| 2016-12-31 | $17.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | $17.24M derived: sum of 2 quarters · filed 2017-02-17 | $17.23M 10-Q · filed 2017-02-17 | $17.24M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-09-30 | -$48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | -$59.00K 10-Q · filed 2016-11-15 | -$48.00K derived: sum of 3 quarters · filed 2017-08-08 | -$168.00K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | -$11.00K 10-Q · filed 2017-08-08 | $0.00 derived: sum of 2 quarters · filed 2017-08-08 | -$120.00K derived: sum of 3 quarters · filed 2017-08-08 | -$198.00K derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | -$109.00K derived: sum of 2 quarters · filed 2017-06-28 | -$187.00K derived: sum of 3 quarters · filed 2017-06-28 | $4.19M 10-K · filed 2017-06-28 |
| 2015-12-31 | -$120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | -$198.00K derived: sum of 2 quarters · filed 2017-02-17 | $4.18M 10-Q · filed 2017-02-17 | $5.09M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-09-30 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | $4.30M 10-Q · filed 2016-11-15 | $5.21M derived: sum of 3 quarters · filed 2016-11-15 | $5.15M derived: sum of 4 quarters · filed 2016-11-15 |
| 2015-06-30 | $4.38M 10-Q · filed 2016-08-09 | $5.29M derived: sum of 2 quarters · filed 2016-08-09 | $5.23M derived: sum of 3 quarters · filed 2016-08-09 | $5.26M derived: sum of 4 quarters · filed 2016-08-09 |
| 2015-03-31 | $915.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | $852.00K derived: sum of 2 quarters · filed 2016-06-21 | $883.00K derived: sum of 3 quarters · filed 2016-06-21 | $875.00K 10-K · filed 2016-06-21 |
| 2014-12-31 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | -$32.00K derived: sum of 2 quarters · filed 2016-02-16 | -$40.00K 10-Q · filed 2016-02-16 | -$57.00K derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-09-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-10 | $23.00K 10-Q · filed 2015-11-10 | $6.00K derived: sum of 3 quarters · filed 2015-11-10 | -$110.00K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | -$8.00K 10-Q · filed 2015-08-07 | -$25.00K derived: sum of 2 quarters · filed 2015-08-07 | -$141.00K derived: sum of 3 quarters · filed 2015-08-07 | |
| 2014-03-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-16 | -$133.00K derived: sum of 2 quarters · filed 2015-06-16 | -$445.00K 10-K · filed 2015-06-16 | |
| 2013-12-31 | -$116.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | -$428.00K 10-Q · filed 2015-02-12 | ||
| 2013-09-30 | -$312.00K 10-Q · filed 2014-11-13 | |||
| 2013-03-31 | -$370.00K 10-K · filed 2014-06-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |